These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6491654)

  • 21. Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro.
    Mulder AH; Draper R; Sminia P; Schoffelmeer AN; Stoof JC
    Eur J Pharmacol; 1985 Jan; 107(3):291-7. PubMed ID: 3979429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamate ester derivatives as potential prodrugs of the presynaptic dopamine autoreceptor agonist (-)-3-(3-hydroxyphenyl)-N-propylpiperidine.
    Thorberg SO; Berg S; Lundström J; Pettersson B; Wijkström A; Sanchez D; Lindberg P; Nilsson JL
    J Med Chem; 1987 Nov; 30(11):2008-12. PubMed ID: 3669008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and dopamine autoreceptor activity of a 5-(methylmercapto)methyl-substituted derivative of (+/-)-3-PPP (3-(3-hydroxyphenyl)-1-n-propylpiperidine).
    Kelly TR; Howard HR; Koe BK; Sarges R
    J Med Chem; 1985 Sep; 28(9):1368-71. PubMed ID: 3928893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural and biochemical effects of subchronic treatment with raclopride in the rat: tolerance and brain monoamine receptor sensitivity.
    Ahlenius S; Ericson EL; Högberg K; Wijkström A
    Pharmacol Toxicol; 1991 Apr; 68(4):302-9. PubMed ID: 1907738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subchronic methamphetamine treatment selectively attenuates apomorphine-induced decrease in 3,4-dihydroxyphenylacetic acid level in mesolimbic dopaminergic regions.
    Watanabe H
    Life Sci; 1985 Dec; 37(24):2319-25. PubMed ID: 4068904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine.
    Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1989 Jul; 33(3):595-9. PubMed ID: 2511575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
    Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.
    Clark D; Hjorth S; Carlsson A
    J Neural Transm; 1985; 62(3-4):171-207. PubMed ID: 2863323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmoset.
    Nomoto M; Jenner P; Marsden CD
    Eur J Pharmacol; 1986 Feb; 121(1):123-8. PubMed ID: 3082655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two automated locomotor activity tests for dopamine autoreceptor agonists.
    Schreur PJ; Nichols NF
    Pharmacol Biochem Behav; 1986 Jul; 25(1):255-61. PubMed ID: 2875471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
    Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B
    J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
    Johnels B
    Pharmacol Biochem Behav; 1982 Aug; 17(2):283-9. PubMed ID: 7134238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effect of the racemic mixture and the (-)enantiomer of N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptor.
    Markstein R; Lahaye D
    J Neural Transm; 1983; 58(1-2):43-53. PubMed ID: 6317801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolved 3-(3-hydroxyphenyl)-N-n-propylpiperidine and its analogues: central dopamine receptor activity.
    Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson AM; Thorberg SO; Nilsson JL; Svensson K; Hjorth S
    J Med Chem; 1984 Aug; 27(8):1030-6. PubMed ID: 6086923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The search for selective dopaminergic autoreceptor agonists.
    Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson A; Nilsson JL
    J Neural Transm Suppl; 1983; 18():131-7. PubMed ID: 6576112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sexually differentiated actions of 3-PPP enantiomers on prolactin secretion.
    Carlsson M; Eriksson E; Nilsson C; Carlsson A
    Neuropharmacology; 1986 Aug; 25(8):951-4. PubMed ID: 3774120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP and (-)-3-PPP by recording of yawning behaviour in rats.
    Ståhle L; Ungerstedt U
    Eur J Pharmacol; 1984 Feb; 98(2):307-10. PubMed ID: 6714314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indolizidine and quinolizidine derivatives of the dopamine autoreceptor agonist 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP).
    Bøgesø KP; Arnt J; Lundmark M; Sundell S
    J Med Chem; 1987 Jan; 30(1):142-50. PubMed ID: 3806591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.